Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gaykema SB"'
Autor:
Gaykema SB, de Jong JR, Perik PJ, Brouwers AH, Schroder CP, Oude Munnink TH, Bongaerts AH, de Vries EG, Lub-de Hooge MN
Publikováno v:
Molecular Imaging.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=erc_________::ba03d214b3a70c989c2297523e6e6461
Autor:
Nienhuis HH; Department of Medical Oncology, University Medical Center Groningen, The Netherlands., Gaykema SB; Department of Medical Oncology, University Medical Center Groningen, The Netherlands., Timmer-Bosscha H; Department of Medical Oncology, University Medical Center Groningen, The Netherlands., Jalving M; Department of Medical Oncology, University Medical Center Groningen, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, The Netherlands., Lub-de Hooge MN; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, The Netherlands; Department of Hospital and Clinical Pharmacy, University Medical Center Groningen, The Netherlands., van der Vegt B; Department of Pathology, University Medical Center Groningen, The Netherlands., Overmoyer B; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., de Vries EG; Department of Medical Oncology, University Medical Center Groningen, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, The Netherlands. Electronic address: c.p.schroder@umcg.nl.
Publikováno v:
Pharmacology & therapeutics [Pharmacol Ther] 2015 Mar; Vol. 147, pp. 63-79. Date of Electronic Publication: 2014 Nov 06.
Autor:
Terwisscha van Scheltinga AG; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Hospital and Clinical Pharmacy, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Berghuis P; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Nienhuis HH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Timmer-Bosscha H; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Pot L; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Gaykema SB; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lub-de Hooge MN; Department of Hospital and Clinical Pharmacy, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kosterink JG; Department of Hospital and Clinical Pharmacy, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Vries EG; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: c.p.schroder@umcg.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2014 Sep; Vol. 50 (14), pp. 2508-16. Date of Electronic Publication: 2014 Jul 12.
Autor:
Gaykema SB; Departments of Medical Oncology., Schröder CP; Departments of Medical Oncology, c.p.schroder@umcg.nl., Vitfell-Rasmussen J; Section of Medicine, UK and Drug Development Unit, The Institute of Cancer Research, The Royal Marsden Hospital, Sutton, United Kingdom; and., Chua S; Section of Medicine, UK and Drug Development Unit, The Institute of Cancer Research, The Royal Marsden Hospital, Sutton, United Kingdom; and., Oude Munnink TH; Departments of Medical Oncology., Brouwers AH; Nuclear Medicine and Molecular Imaging., Bongaerts AH; Radiology and., Akimov M; Novartis Pharma AG, Basel, Switzerland and Novartis Pharmaceuticals, Cambridge, Massachusetts., Fernandez-Ibarra C; Novartis Pharma AG, Basel, Switzerland and Novartis Pharmaceuticals, Cambridge, Massachusetts., Lub-de Hooge MN; Nuclear Medicine and Molecular Imaging, Hospital and Clinical Pharmacy, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., de Vries EG; Departments of Medical Oncology., Swanton C; Section of Medicine, UK and Drug Development Unit, The Institute of Cancer Research, The Royal Marsden Hospital, Sutton, United Kingdom; and., Banerji U; Section of Medicine, UK and Drug Development Unit, The Institute of Cancer Research, The Royal Marsden Hospital, Sutton, United Kingdom; and.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2014 Aug 01; Vol. 20 (15), pp. 3945-54.
Autor:
Gaykema SB; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., Brouwers AH, Lub-de Hooge MN, Pleijhuis RG, Timmer-Bosscha H, Pot L, van Dam GM, van der Meulen SB, de Jong JR, Bart J, de Vries J, Jansen L, de Vries EG, Schröder CP
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2013 Jul; Vol. 54 (7), pp. 1014-8. Date of Electronic Publication: 2013 May 07.
Autor:
Gaykema SB; Department of Medical Oncology, University Medical Centre Groningen, PO Box 30001, 9700 RB Groningen, the Netherlands., Brouwers AH, Hovenga S, Lub-de Hooge MN, de Vries EG, Schröder CP
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2012 Feb 20; Vol. 30 (6), pp. e74-5. Date of Electronic Publication: 2011 Dec 27.